| Nov 7 |
Applied Therapeutics GAAP EPS of -$0.48, revenue of $0.12M
|
| Nov 7 |
Applied Therapeutics Reports Third Quarter 2024 Financial Results
|
| Nov 5 |
Applied Therapeutics to Present at the 2024 UBS Global Healthcare Conference
|
| Oct 29 |
Applied Therapeutics (APLT) Upgraded to Buy: Here's What You Should Know
|
| Oct 29 |
Is Applied Therapeutics (APLT) Outperforming Other Medical Stocks This Year?
|
| Oct 10 |
Are Medical Stocks Lagging Applied Therapeutics (APLT) This Year?
|
| Sep 24 |
Is Applied Therapeutics (APLT) Stock Outpacing Its Medical Peers This Year?
|
| Sep 23 |
All You Need to Know About Applied Therapeutics (APLT) Rating Upgrade to Buy
|
| Sep 19 |
APLT Stock Soars 69% on Positive Update on Galactosemia Drug NDA
|
| Sep 19 |
Applied Therapeutics: AdCom Decision Takes Govorestat Approval A Step Closer
|
